People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

16 Sep 2014
Price Change (% chg)

$0.61 (+0.94%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Kaelin, William 

Brief Biography

Dr. William G. Kaelin Jr., M.D., is Independent Director of Eli Lilly and Co. He is Professor, Department of Medicine and Associate Director, Basic Science; Dana-Farber/Harvard Cancer Center Dr. Kaelin, who is currently serving under interim election, joined the board in June 2012 and was referred to the directors and corporate governance committee by an incumbent independent director. Dr. Kaelin is a professor in the Department of Medicine at the Dana-Farber Cancer Institute and at the Brigham and Women's Hospital, Harvard Medical School, where he began his career as an independent investigator in 1992. He currently serves as associate director, Basic Science, for the Dana-Farber/Harvard Cancer Center. Dr. Kaelin is a prominent member of the medical research community and has received broad recognition for his work in oncology research, including the Canada Gairdner International Award and the Lefoulon-Delalande Prize from the Institute of France. Dr. Kaelin is a member of the Institute of Medicine, the National Academy of Sciences, and the Association of American Physicians.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter


Derica Rice


Maria Crowe


Jan Lundberg


Melissa Barnes


Michael Harrington

As Of 30 Dec 2013
Search Stocks